Reginald Christophe Xavier Brys

This inventor holds 20 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 14 EPO patents. Top assignees: Galapagos Nv, Janssen Pharmaceutica Nv, Morphosys Ag. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reginald Christophe Xavier Brys. Retrieved from https://idiyas.com/inventor/reginald-christophe-xavier-brys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 7)

% Patents Active = 75.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 23)

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Romainville, FR (2020)
Mechelen, BE (2012 - 2023)

Company Filing History:

Janssen Pharmaceutica Nv

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12383544 - Methods for the treatment of polycystic kidney disease (2025-08-12),

2. 12264156 - Compounds and pharmaceutical compositions thereof for the treatment of diseases (2025-04-01),

3. 11564923 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2023-01-31),

4. 11072611 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2021-07-27),

5. 10815297 - Antagonists of IL17C for the treatment of inflammatory disorders (2020-10-27),

6. 10604566 - Antagonists of IL-17C for the treatment and/or prevention of atopic dermatitis (2020-03-31),

7. 10526329 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2020-01-07),

8. 10508111 - 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors (2019-12-17),

9. 10125132 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2018-11-13),

10. 9951337 - Methods and means for treatment of osteoarthritis (2018-04-24),

11. 9945843 - Methods for identifying compounds that inhibit G protein-coupled receptor (GPR84) agonist-stimulated chemotaxis (2018-04-17),

12. 9796719 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2017-10-24),

13. 9670204 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2017-06-06),

14. 9249141 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2016-02-02),

15. 8993590 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2015-03-31),

Title: Reginald Christophe Xavier Brys: Pioneering Inventor in the Field of Pharmaceuticals

Introduction: Reginald Christophe Xavier Brys, a prolific inventor hailing from Mechelen, Belgium, continues to captivate and inspire the next generation of inventors with his innovative thinking and unwavering dedication to creating a positive impact on society.

Latest Patents: With a remarkable portfolio of 18 patents to his name, Brys has recently made groundbreaking strides in the pharmaceutical industry. His latest patents include compounds and pharmaceutical compositions for the treatment of inflammatory disorders. These compounds have shown promise in addressing a wide range of conditions, from allergic and autoimmune diseases to metabolic disorders and cartilage malformations.

Career Highlights: Brys has left an indelible mark on the world of innovations through his work with renowned companies such as Galapagos NV and Morphosys AG. His pioneering research and inventions have not only enhanced the understanding of various medical conditions but have also paved the way for novel treatment approaches in the field of pharmaceuticals.

Collaborations: Throughout his illustrious career, Brys has collaborated with esteemed professionals in the field. Among his notable coworkers are Agnès Marie Joncour and Nicolas Desroy, who have contributed significantly to the success of his innovative projects and patents.

Conclusion: Reginald Christophe Xavier Brys stands as a testament to the power of creative thinking and relentless dedication in the realm of inventions. His legacy as an inventor will undoubtedly continue to shape the future of pharmaceutical innovations, inspiring generations to come to push the boundaries of what is possible in the pursuit of a better and healthier society.

Profile summary based on public USPTO records.